Credit Suisse’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-213,914
| Closed | -$5.16M | – | 3307 |
|
|
2023
Q1 | $5.16M | Buy |
213,914
+124,144
| +138% | +$2.99M | 0.01% | 1274 |
|
|
2022
Q4 | $949K | Buy |
89,770
+54,093
| +152% | +$572K | ﹤0.01% | 2364 |
|
|
2022
Q3 | $160K | Buy |
35,677
+346
| +1% | +$1.55K | ﹤0.01% | 3301 |
|
|
2022
Q2 | $140K | Sell |
35,331
-1,749
| -5% | -$6.93K | ﹤0.01% | 3432 |
|
|
2022
Q1 | $271K | Sell |
37,080
-1,081
| -3% | -$7.9K | ﹤0.01% | 3252 |
|
|
2021
Q4 | $214K | Buy |
38,161
+2,454
| +7% | +$13.8K | ﹤0.01% | 3420 |
|
|
2021
Q3 | $227K | Buy |
35,707
+4,541
| +15% | +$28.9K | ﹤0.01% | 3344 |
|
|
2021
Q2 | $262K | Sell |
31,166
-4,609
| -13% | -$38.7K | ﹤0.01% | 3333 |
|
|
2021
Q1 | $375K | Sell |
35,775
-11,839
| -25% | -$124K | ﹤0.01% | 3086 |
|
|
2020
Q4 | $807K | Buy |
47,614
+23,374
| +96% | +$396K | ﹤0.01% | 2701 |
|
|
2020
Q3 | $311K | Buy |
24,240
+493
| +2% | +$6.33K | ﹤0.01% | 2902 |
|
|
2020
Q2 | $335K | Buy |
23,747
+1,927
| +9% | +$27.2K | ﹤0.01% | 2892 |
|
|
2020
Q1 | $200K | Sell |
21,820
-101,948
| -82% | -$934K | ﹤0.01% | 3043 |
|
|
2019
Q4 | $1.84M | Buy |
+123,768
| New | +$1.84M | ﹤0.01% | 2098 |
|